Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

ClinicalTrials.gov ID: NCT03268941

Public ClinicalTrials.gov record NCT03268941. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 12:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-Part, Randomized, Double Blind and Open-Label, Placebo and Active-Comparator Controlled Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics for TAK-906 in Subjects With Diabetes Mellitus and Gastroparesis or With Idiopathic Gastroparesis

Study identification

NCT ID
NCT03268941
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Millennium Pharmaceuticals, Inc.
Industry
Enrollment
51 participants

Conditions and interventions

Interventions

  • TAK-906 Maleate Drug
  • Metaclopramide Drug
  • TAK-906 Maleate Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 25, 2017
Primary completion
Mar 8, 2018
Completion
Mar 8, 2018
Last update posted
Jan 5, 2021

2017 – 2018

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
9171 West Thunderbird Road Peoria Arizona 85381
850 North Kolb Road Tucson Arizona 85710
11219 Financial Centre Parkway Little Rock Arkansas 72211
13055 Southwest 42nd Street Miami Florida 33175
8200 Southwest 117th Avenue Miami Florida 33183
125 Clairemont Avenue Decatur Georgia 30030
616 South Washington Street Bastrop Louisiana 71220
6035 Shallowford Road Chattanooga Tennessee 37421
26 Stonecreek Circle Jackson Tennessee 38305

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03268941, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03268941 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →